Abstract:2423 Cyclopentenone prostaglandins (cyPGs) exert diverse cellular functions, such as anti-inflammatory and cytoprotective effects, via multiple mechanisms. 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), a representative cyPG of the J series, has been reported to directly inhibit the activity of the transcription factors, such as AP-1 and NF-κB. In the present study, we found that human breast cancer (MCF-7) cells treated with 15d-PGJ2 rapidly accumulated the tumor suppressor gene p53 protein in both cytosolic and nuclear fractions. Under the same experimental conditions, however, the mRNA level of p53 remained unchanged. In addition, 15d-PGJ2 significantly decreased p53 DNA binding as well as activity of p21WAF1 promoter containing a p53-binding site in MCF-7 cells. We observed that the majority of accumulated p53 in 15d-PGJ2-treated MCF-7 cells represents the changed mutant form of p53 and ubiquitinated p53 as assessed by immunoprecipitation and immunofluorscence assays. Murine double-minute 2 (MDM2), a zinc finger protein, is known to negatively regulate p53. 15d-PGJ2 treatment caused failure of proper p53-MDM2 interaction in MCF-7 cells which could stabilize the abnormal p53 protein by blocking MDM2-mediated degradation. We hypothesized that 15d-PGJ2 could covalently modify p53, which may hamper DNA binding of this redox-sensitive transcription factor. In support of this assumption, 15d-PGJ2 treated to both recombinant p53 and MCF-7 nuclear extracts diminished the DNA binding ability of p53 in a concentration-dependent manner. In addition, covalent binding of 15d-PGJ2 to p53 occurred upon incubation of recombinant p53 with biotinylated 15d-PGJ2. The incorporation of biotinylated 15d-PGJ2 into p53 was abolished by excess 15d-PGJ2 and restored in the presence of dithiothreitol. By using 35S-labeled translated p53, we could identify to cysteine 277 as a putative site of modification of p53 by 15d-PGJ2. The DNA binding ability of a mutant p53 in which Cys-277 was substituted by Ala was virtually unaffected by 15d-PGJ2. It is anticipated that the electrophilic carbon center located in the α,β-unsaturated carbonyl moiety of the cyclopentenone ring might be critical for the 15d-PGJ2-induced covalent modification of p53 at Cys-277 which hampered its degradation as well as DNA binding. MCF-7 cells treated with 9,10-dihydro-15-deoxy-Δ12,14-prostaglandin J2 that lacks the electrophilic α,β-unsaturated functionality failed to inhibit p53 DNA binding activity, lending further support to the above assumption. In conclusion, 15d-PGJ2, by covalently modifying cysteine 277 of p53, abrogates p53 DNA binding, leading to functional inactivation of this tumor suppressor.

Protein adduction causes non-mutational inhibition of p53 tumor suppressor

Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.

Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents.

Cysteine 277 As a Putative Site of P53 for Covalent Modification with 15-Deoxy-δ12,14-prostaglandin J2 : Implications for Functional Inactivation of P53

Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl-2'-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer

Gain of Function of Mutant P53 by Coaggregation with Multiple Tumor Suppressors

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress

Antisense Gadd45 Expression Results In Decreased Dna Repair And Sensitizes Cells To Uv-Irradiation Or Cisplatin

Role of P53 in Cellular Response to Anticancer Nucleoside Analog-Induced Dna Damage

Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant P53 Promotes Transactivation-Independent Mitochondrial Cell Death.

Data from Ribosomal Protein S27-like, a p53-Inducible Modulator of Cell Fate in Response to Genotoxic Stress

The Status of p53 Oligomeric and Aggregation States in Cancer

p53: The Multifaceted Roles of Covalent Modifications in Cancer

Suppression of Mismatched Mutation by P53: A Mechanism for Guarding Genomic Integrity

Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.

Functional Analysis of the Acetylation of Human P53 in DNA Damage Responses

Comparison of genotoxic versus nongenotoxic stabilization of p53 provides insight into parallel stress-responsive transcriptional networks

Multisite Aggregation Of P53 And Implications For Drug Rescue

Modulation of (±)-anti-BPDE mediated p53 accumulation by inhibitors of protein kinase C and poly(ADP-ribose) polymerase

Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators

Ribosomal Protein S27-Like, A P53-Inducible Modulator Of Cell Fate In Response To Genotoxic Stress